Literature DB >> 10763087

The pathology of smoking-related lung diseases.

M C Aubry1, J L Wright, J L Myers.   

Abstract

A broad range of non-neoplastic pulmonary lesions is associated with cigarette smoking including airway diseases with airflow limitation, vascular alterations and interstitial lung diseases characterized by diffuse radiographic abnormalities and restricted lung volumes. This article focuses on the pathology of smoking-related emphysema, alterations of large airways, alterations of pulmonary vessels, respiratory bronchiolitis associated interstitial lung disease (RB-ILD), desquamative interstitial pneumonia (DIP), and eosinophilic granuloma (EG).

Entities:  

Mesh:

Year:  2000        PMID: 10763087     DOI: 10.1016/s0272-5231(05)70005-8

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  11 in total

1.  Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice.

Authors:  Gregory T Motz; Bryan L Eppert; Scott C Wesselkamper; Jennifer L Flury; Michael T Borchers
Journal:  Am J Respir Crit Care Med       Date:  2010-02-04       Impact factor: 21.405

Review 2.  Cigarette smoking and diffuse lung disease.

Authors:  Rajesh R Patel; Jay H Ryu; Robert Vassallo
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 3.  Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases.

Authors:  Athol U Wells; Andrew G Nicholson; David M Hansell
Journal:  Thorax       Date:  2007-10       Impact factor: 9.139

4.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.

Authors:  William D Travis; Ulrich Costabel; David M Hansell; Talmadge E King; David A Lynch; Andrew G Nicholson; Christopher J Ryerson; Jay H Ryu; Moisés Selman; Athol U Wells; Jurgen Behr; Demosthenes Bouros; Kevin K Brown; Thomas V Colby; Harold R Collard; Carlos Robalo Cordeiro; Vincent Cottin; Bruno Crestani; Marjolein Drent; Rosalind F Dudden; Jim Egan; Kevin Flaherty; Cory Hogaboam; Yoshikazu Inoue; Takeshi Johkoh; Dong Soon Kim; Masanori Kitaichi; James Loyd; Fernando J Martinez; Jeffrey Myers; Shandra Protzko; Ganesh Raghu; Luca Richeldi; Nicola Sverzellati; Jeffrey Swigris; Dominique Valeyre
Journal:  Am J Respir Crit Care Med       Date:  2013-09-15       Impact factor: 21.405

5.  Pharmacologic agents for smoking cessation: a clinical review.

Authors:  Dilip R Patel; Cynthia Feucht; Lesley Reid; Neil D Patel
Journal:  Clin Pharmacol       Date:  2010-04-07

6.  Determinants of active pulmonary tuberculosis in Ambo Hospital, West Ethiopia.

Authors:  Tenna Ephrem; Bezatu Mengiste; Frehiwot Mesfin; Wanzahun Godana
Journal:  Afr J Prim Health Care Fam Med       Date:  2015-09-07

7.  Clinical and radiological features of idiopathic interstitial pneumonias (IIPs): a pictorial review.

Authors:  Stefano Palmucci; Federica Roccasalva; Silvia Puglisi; Sebastiano Emanuele Torrisi; Virginia Vindigni; Letizia Antonella Mauro; Giovanni Carlo Ettorre; Marina Piccoli; Carlo Vancheri
Journal:  Insights Imaging       Date:  2014-05-22

8.  Pulmonary Langerhans Cell Histiocytosis with Lytic Bone Involvement in an Adult Smoker: Regression following Smoking Cessation.

Authors:  B Routy; J Hoang; J Gruber
Journal:  Case Rep Hematol       Date:  2015-02-18

9.  A case control study of risk factors associated with pulmonary tuberculosis in romania: experience at a clinical hospital of pneumology.

Authors:  Pacifique Ndishimye; Bianca Domokos; Jonathan Stillo; Fouad Seghrouchni; Oulaya Mrabet; Daniela Homorodean; Carmen Monica Pop; Abderrahim Sadak
Journal:  Clujul Med       Date:  2017-01-15

10.  Mendelian randomization analysis of arsenic metabolism and pulmonary function within the Hispanic Community Health Study/Study of Latinos.

Authors:  Molly Scannell Bryan; Tamar Sofer; Majid Afshar; Yasmin Mossavar-Rahmani; H Dean Hosgood; Naresh M Punjabi; Donglin Zeng; Martha L Daviglus; Maria Argos
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.